During the past several decades, left ventricular assist devices (LVADs) have become a
valuable therapeutic option in the management of advanced systolic heart failure. Durable …

There is increased scrutiny on the quality in health care with particular emphasis on
institutional heart transplant survival outcomes. An important aspect of successful …

Objectives: The aim of this study was to determine renal outcomes after left ventricular assist
device (LVAD) implantation. Background: Renal dysfunction before LVAD placement is …

Abstract The 2011 Canadian Cardiovascular Society Heart Failure (HF) Guidelines Focused
Update reviews the recently published clinical trials that will potentially impact on …

The presence of vortical flow structures that develop inside different cardiac chambers is
shown to correlate with functional status of heart, and significantly affects the cardiac …

Congestive heart failure (HF) remains a serious burden in the Western World. Despite
advances in pharmacotherapy and resynchronization, many patients have progression to …

Implantable left ventricular assist devices (LVADs) are increasingly being used as a bridge
to transplantation or as destination therapy in patients with end stage heart failure refractory …

Background The hemodynamic vascular consequences of implanting left ventricular assist
devices (LVADs) have not been studied in detail. We investigated the effect of LVAD …

Background Psychosocial factors and physical health are associated with increased
psychological distress post-heart transplant. Integrating findings from qualitative studies …

The therapeutic use of ventricular assist devices (VADs) for end-stage heart failure (HF)
patients who are ineligible for transplant has increased steadily in the last decade. In …